Cargando…

Inhibition of HMGB1 Overcomes Resistance to Radiation and Chemotherapy in Nasopharyngeal Carcinoma

OBJECTIVE: This study aimed to investigate the effect of high mobility group protein B1 (HMGB1) on chemoresistance and radioresistance in nasopharyngeal carcinoma (NPC). MATERIALS AND METHODS: HMGB1-knockout HK1 cell lines were generated using clustered regularly interspaced short palindromic repeat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Xuewei, Cong, Jianan, Lin, Zhang, Sun, Jing, Yang, Ben, Li, Aipeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236242/ https://www.ncbi.nlm.nih.gov/pubmed/32523355 http://dx.doi.org/10.2147/OTT.S239243

Ejemplares similares

lncRNA MIAT/HMGB1 Axis Is Involved in Cisplatin Resistance via Regulating IL6-Mediated Activation of the JAK2/STAT3 Pathway in Nasopharyngeal Carcinoma
por: Zhu, Xuewei, et al.
Publicado: (2021)

Inhibition of livin overcomes radioresistance in nasopharyngeal carcinoma cells
por: Ma, Fei, et al.
Publicado: (2020)

LncRNA ANCR promotes proliferation and radiation resistance of nasopharyngeal carcinoma by inhibiting PTEN expression
por: Ma, Xingkai, et al.
Publicado: (2018)

Expression of RRM1 and its association with resistancy to gemcitabine-based chemotherapy in advanced nasopharyngeal carcinoma
por: Zhao, Li-Ping, et al.
Publicado: (2012)

Role of chemotherapy in nasopharyngeal carcinoma
por: Paiar, Fabiola, et al.
Publicado: (2012)

Wnt5a-mediated autophagy promotes radiation resistance of nasopharyngeal carcinoma
por: Lu, Zhaoyi, et al.
Publicado: (2022)

Role of chemotherapy in stage IIb nasopharyngeal carcinoma
por: Pan, Xin-Bin, et al.
Publicado: (2012)

Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
por: Li, Wen-Fei, et al.
Publicado: (2016)

MET inhibition overcomes radiation resistance of glioblastoma stem‐like cells
por: De Bacco, Francesca, et al.
Publicado: (2016)

Targeting Notch to overcome radiation resistance
por: Yahyanejad, Sanaz, et al.
Publicado: (2015)

Increased Angiogenin Expression Correlates With Radiation Resistance and Predicts Poor Survival for Patients With Nasopharyngeal Carcinoma
por: Guo, Shan-Shan, et al.
Publicado: (2021)

Efficacy of BIBF 1120 or BIBF 1120 plus chemotherapy on nasopharyngeal carcinoma in vitro and in vivo
por: Xue, Cong, et al.
Publicado: (2016)

Genetic Variations in Radiation and Chemotherapy Drug Action Pathways and Survival in locoregionally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy
por: Liu, Huai, et al.
Publicado: (2013)

Survival Benefit of Adding Chemotherapy to Intensity Modulated Radiation in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma
por: Ji, Xuemei, et al.
Publicado: (2013)

Chemotherapy use and survival in stage II nasopharyngeal carcinoma
por: Pan, Xin-Bin, et al.
Publicado: (2017)

Nuclear exosome HMGB3 secreted by nasopharyngeal carcinoma cells promotes tumour metastasis by inducing angiogenesis
por: Zhang, Kaiwen, et al.
Publicado: (2021)

Targeted chemotherapy overcomes drug resistance in melanoma
por: Yue, Jingyin, et al.
Publicado: (2020)

Overcoming Chemotherapy Resistance in Germ Cell Tumors
por: Országhová, Zuzana, et al.
Publicado: (2022)

Pharmacological Strategies for Overcoming Multidrug Resistance to Chemotherapy
por: Fedotcheva, T. A., et al.
Publicado: (2023)

Dose escalation via brachytherapy boost for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy and combined chemotherapy
por: Chao, Hsing-Lung, et al.
Publicado: (2017)

Efficacy of Chemotherapy in Survival of Stage I Nasopharyngeal Carcinoma
por: Ma, Jia-Lin, et al.
Publicado: (2021)

Inhibition of IGF1-R overcomes IGFBP7-induced chemotherapy resistance in T-ALL
por: Bartram, Isabelle, et al.
Publicado: (2015)

Sensorineural Hearing Loss after Combined Intensity Modulated Radiation Therapy and Cisplatin-Based Chemotherapy for Nasopharyngeal Carcinoma()()
por: Wang, Jin, et al.
Publicado: (2015)

HMGB1, anti-HMGB1 antibodies, and ratio of HMGB1/anti-HMGB1 antibodies as diagnosis indicator in fever of unknown origin
por: Chen, Mingkun, et al.
Publicado: (2021)

The Current Role of Adjuvant Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma
por: Su, Lin, et al.
Publicado: (2021)

Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: Experience of 370 consecutive cases
por: Lin, Shaojun, et al.
Publicado: (2010)

Erlotinib: An enhancer of radiation therapy in nasopharyngeal carcinoma
por: ZHANG, HUAN-HUAN, et al.
Publicado: (2013)

Combining antiangiogenic therapy and radiation in nasopharyngeal carcinoma
por: Chen, Zhuo, et al.
Publicado: (2015)

CT-707 overcomes hypoxia-mediated sorafenib resistance in Hepatocellular carcinoma by inhibiting YAP signaling
por: Chen, Zibo, et al.
Publicado: (2022)

High VCAM-1 Predicts Poor Prognosis and is Associated with Chemotherapy Resistance in Nasopharyngeal Carcinoma
por: Huang, Yu, et al.
Publicado: (2021)

Retrospective Analysis of a Modified Irrigation Method for Nasopharyngeal Carcinoma Patients With Post-Radiation Nasopharyngeal Necrosis
por: Xiao, Yun, et al.
Publicado: (2021)

LncRNA SNHG5 promotes nasopharyngeal carcinoma progression by regulating miR-1179/HMGB3 axis
por: Liu, Dengtao, et al.
Publicado: (2020)

ATR activated by EB virus facilitates chemotherapy resistance to cisplatin or 5-fluorouracil in human nasopharyngeal carcinoma
por: Zhang, Bo, et al.
Publicado: (2019)

Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy
por: Kim, Byeong Mo, et al.
Publicado: (2015)

Hyperthermia: The Optimal Treatment to Overcome Radiation Resistant Hypoxia
por: Elming, Pernille B., et al.
Publicado: (2019)

Understanding the Radiobiology of Vestibular Schwannomas to Overcome Radiation Resistance
por: Thielhelm, Torin P., et al.
Publicado: (2021)

Overcoming Immune Resistance With Radiation Therapy in Prostate Cancer
por: Mulvey, Arthur, et al.
Publicado: (2022)

HMGB1 enhances chemotherapy resistance in multiple myeloma cells by activating the nuclear factor-κB pathway
por: Ning, Jing, et al.
Publicado: (2021)

Radiation-Guided Peptide Delivery in a Mouse Model of Nasopharyngeal Carcinoma
por: Lin, Pei-cheng, et al.
Publicado: (2016)

High NEK2 confers to poor prognosis and contributes to cisplatin‐based chemotherapy resistance in nasopharyngeal carcinoma
por: Xu, He, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_570d2mhkeol2qekhfkas39tvvc